C12N 2710/16645
Special targeting system for viral vectors
C12N2710/16645 (Special targeting system for viral vectors) appears on 15 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 21
- Assignees
- 12
- Inventors
- 42
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 4 |
| 2017 | 1 | 2 |
| 2018 | 0 | 0 |
| 2019 | 4 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 2 |
| 2022 | 0 | 2 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 3 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant herpes simplex virus for multiple targeting and use thereof19 May 2026US 12,629,399 B2Gencellmed Inc.
- Antigenically stealthed oncolytic viruses16 Sep 2025US 12,414,973 B2The Trustees of the University of Pennsylvania
- Recombinant herpes simplex virus having modified glycoprotein gH for retargeting and use thereof11 Mar 2025US 12,246,048 B2Gencellmed Inc.
- Oncolytic viral vectors and uses thereof28 Jan 2025US 12,208,126 B2Virogin Biotech Canada Ltd
- Oncolytic HSV vector30 Jan 2024US 11,883,448 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Il13ra2-targeting herpes simplex virus and anti-il13ra2 antibody or antigen-binding fragment thereof11 Jun 2026US 2026/0159594 A1The University of Tokyo
- Method of delivery of fusogenic oncolytic virus and therapeutic molecules6 Nov 2025US 2025/0339481 A1The Brigham and Women S Hospital, Inc.
- Engineered oncolytic herpesviruses13 Feb 2025US 2025/0049867 A1
- Universal retargeting of oncolytic hsv11 Jul 2024US 2024/0226207 A1
- Oncolytic viral vectors and uses thereof3 Aug 2023US 2023/0241140 A1Oncorus, Inc.
Most cited
By later US patents
- Herpes simplex virus amplicon vector targeting system and method of using same9US 6,673,602 B1The General Hospital Corporation · 2004
- Oncolytic HSV vector7US 10,172,893 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2019
- Virion display array for profiling functions and interactions of human membrane proteins5US 10,208,290 B2The Johns Hopkins University · 2019
- Oncolytic HSV vector4US 10,576,115 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2020
- Oncolytic HSV vector3US 10,188,686 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2019